查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1985969

全球乳房切片器材市场：市场规模、份额和趋势分析（按产品、手术、引导技术、最终用途和地区划分），细分市场预测（2026-2033 年）

Breast Biopsy Devices Market Size, Share & Trends Analysis Report By Product, By Procedure, By Guidance Technology, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

乳房切片设备市场概述

2025年全球乳房切片设备市场规模估计为35.2亿美元，预计2033年将达56亿美元。

预计2026年至2033年，该市场将以6.04%的复合年增长率成长。推动该市场成长的主要因素是全球乳癌发生率的上升以及对早期准确诊断需求的增加。

随着全国筛检计画的扩展和人们对定期乳房X光摄影意识的提高，越来越多的异常情况被发现，需要切片检查。微创和影像引导切片检查技术的进步正在提高诊断准确性和患者的舒适度。

此外，由于医疗基础设施和门诊设施的扩建，全球范围内进行的检测数量也在增加。根据Breastcancer.org网站估计，到2026年，美国将有约42,140名女性死于乳癌，这表明儘管早期检测和治疗取得了进展，但乳癌造成的死亡负担依然沉重。

全球乳癌负担日益加重，是乳房切片设备产业发展的主要驱动力。随着全球新发病例持续增加，精准快速诊断程序的需求也显着成长。乳房切片设备在影像检查检查提示观察的情况下，对于确认是否存在恶性肿瘤起着至关重要的作用。因此，发病率的上升直接导致活检数量的增加，从而推动了乳房切片设备行业的持续增长。根据Breastcancer.org网站统计，美国约有八分之一的女性（约13%）在一生中会被诊断出罹患侵袭性乳癌。乳癌约占美国女性每年新发生癌症病例的30%，是女性最常见的癌症之一。这些数据凸显了乳癌在美国造成的巨大影响和持续的负担。

目录

第一章：分析方法和范围

第二章执行摘要

第三章：乳房切片设备市场：影响因素、趋势与范围

  • 市场历史及展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 乳房切片设备市场分析工具
    • 波特五力分析
    • PESTEL 分析

第四章：乳房切片设备市场：按产品分類的估算与趋势分析

  • 全球乳房切片设备市场：按产品分類的波动分析（2025-2033 年）
  • 全球乳房切片设备市场：市场规模与趋势分析（按产品分类）（2021-2033 年）
    • 切片检查引导系统
    • 切片检查驱动器/牙科手机
    • 切片检查台
    • 切片检查耗材
    • 其他消耗品

第五章：乳房切片器械市场：依手术类型分類的估算与趋势分析

  • 全球乳房切片器械市场：按手术方式分類的波动分析（2025-2033 年）
  • 全球乳房切片器械市场：按手术方式分類的市场规模和趋势分析（2021-2033 年）
    • 真空辅助切片检查（VAB）
    • 核心针穿刺切片（CNB）
    • 细针穿刺切片检查（FNAB）
    • 手术（开放式）切片检查
    • 液态生物检体

第六章：乳房切片设备市场：依感应技术分類的估算与趋势分析

  • 全球乳房切片设备市场：按诱导技术分類的波动分析（2025-2033 年）
  • 全球乳房切片设备市场：按感应技术分類的市场规模和趋势分析（2021-2033 年）
    • 在超音波引导下
    • 乳房X光摄影/立体定向
    • 磁共振引导

第七章：乳房切片设备市场：依最终用途分類的估算与趋势分析

  • 全球乳房切片设备市场：按最终用途分類的波动分析（2025-2033 年）
  • 全球乳房切片设备市场：按最终用途分類的市场规模和趋势分析（2021-2033 年）
    • 医院
    • 门诊手术中心（ASC）
    • 乳房护理专科中心
    • 诊断中心/影像诊断中心

第八章：乳房切片器械市场：区域估算和趋势分析（按产品、手术、诱导技术和最终用途划分）

  • 区域仪錶板
  • 市场规模及趋势分析（2021-2033）
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争情势

  • 近期趋势及影响分析：依主要市场参与企业
  • 公司分类
  • 企业市场占有率分析（2025 年）
  • 企业热力图分析
  • 策略规划
    • 业务拓展
    • 併购
    • 伙伴关係与合作
    • 新产品发布
    • 研究与开发
    • 公司简介
    • Hologic, Inc.
    • Mammotome (Danaher)
    • BD
    • Argon Medical
    • Merit Medical Systems
    • GE HealthCare
    • Cook Medical
    • MOLLI Surgical (Stryker)
    • Planmed Oy
    • Metaltronica Spa
    • Trivitron Healthcare
    • Siemens Healthineers
    • Fujifilm Healthcare
    • INRAD
    • SteryLab
    • Resitu Medical
    • TransMed7, LLC.

目录

第一章：分析方法和范围

第二章执行摘要

第三章：乳房切片设备市场：影响因素、趋势与范围

  • 市场历史及展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 乳房切片设备市场分析工具
    • 波特的分析
    • PESTEL 分析

第四章：乳房切片设备市场：按产品分類的估算与趋势分析

  • 全球乳房切片设备市场：按产品分類的波动分析（2025-2033 年）
  • 全球乳房切片设备市场：市场规模与趋势分析（按产品分类）（2021-2033 年）
    • 切片检查引导系统
    • 切片检查驱动器/牙科手机
    • 切片检查台
    • 切片检查耗材
    • 其他消耗品

第五章：乳房切片器械市场：依手术类型分類的估算与趋势分析

  • 全球乳房切片器械市场：按手术方式分類的波动分析（2025-2033 年）
  • 全球乳房切片器械市场：按手术方式分類的市场规模和趋势分析（2021-2033 年）
    • 真空辅助切片检查（VAB）
    • 核心针穿刺切片（CNB）
    • 细针穿刺切片检查（FNAB）
    • 手术（开放式）切片检查
    • 液态生物检体

第六章：乳房切片设备市场：依感应技术分類的估算与趋势分析

  • 全球乳房切片设备市场：按诱导技术分類的波动分析（2025-2033 年）
  • 全球乳房切片设备市场：按感应技术分類的市场规模和趋势分析（2021-2033 年）
    • 在超音波引导下
    • 乳房X光摄影/立体定向
    • 磁共振引导

第七章：乳房切片设备市场：依最终用途分類的估算与趋势分析

  • 全球乳房切片设备市场：按最终用途分類的波动分析（2025-2033 年）
  • 全球乳房切片设备市场：按最终用途分類的市场规模和趋势分析（2021-2033 年）
    • 医院
    • 门诊手术中心（ASC）
    • 乳房护理专科中心
    • 诊断中心/影像诊断中心

第八章：乳房切片器械市场：区域估算和趋势分析（按产品、手术、诱导技术和最终用途划分）

  • 区域仪錶板
  • 市场规模及趋势分析（2021-2033）
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争情势

  • 近期趋势及影响分析：依主要市场参与企业
  • 公司分类
  • 企业市场占有率分析（2025 年）
  • 企业热力图分析
  • 策略规划
    • 业务拓展
    • 併购
    • 伙伴关係与合作
    • 新产品发布
    • 研究与开发
    • 公司简介
    • Hologic, Inc.
    • Mammotome (Danaher)
    • BD
    • Argon Medical
    • Merit Medical Systems
    • GE HealthCare
    • Cook Medical
    • MOLLI Surgical (Stryker)
    • Planmed Oy
    • Metaltronica Spa
    • Trivitron Healthcare
    • Siemens Healthineers
    • Fujifilm Healthcare
    • INRAD
    • SteryLab
    • Resitu Medical
    • TransMed7, LLC.
Product Code: 978-1-68038-981-4

Breast Biopsy Devices Market Summary

The global breast biopsy devices market size was estimated at USD 3.52 billion in 2025 and is projected to reach USD 5.60 billion by 2033, growing at a CAGR of 6.04% from 2026 to 2033. The market is primarily driven by the rising global incidence of breast cancer and increasing demand for early and accurate diagnosis.

The expansion of national screening programs and greater awareness of routine mammography are leading to more abnormalities being detected, requiring biopsy confirmation. Technological advancements in minimally invasive and image-guided biopsy techniques are improving diagnostic precision and patient comfort.

In addition, the expansion of healthcare infrastructure and outpatient care facilities is driving higher procedural volumes worldwide. According to Breastcancer.org, in 2026, it is estimated that about 42,140 women in the U.S. will die from breast cancer, highlighting the continuing mortality burden of the disease despite advances in early detection and treatment.

The increasing global burden of breast cancer is a major driver of the breast biopsy devices industry. As the number of newly diagnosed cases continues to rise worldwide, the demand for accurate and timely diagnostic procedures has grown significantly. Breast biopsy devices play a critical role in confirming malignancy in cases with abnormal imaging findings. Consequently, higher incidence rates directly contribute to increased procedure volumes, driving sustained growth in the breast biopsy devices industry. According to Breastcancer.org, about 1 in 8 women in the U.S. (approximately 13%) will be diagnosed with invasive breast cancer during their lifetime. Each year, breast cancer represents roughly 30% of all newly diagnosed cancers among U.S. women, making it one of the most common cancers affecting women. These statistics highlight the significant impact and ongoing burden of breast cancer nationwide.

Global Breast Biopsy Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global breast biopsy devices market report based on product, procedure, guidance technology, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopsy Guidance Systems
  • Biopsy Drivers & Handpieces
    • Vacuum-Assisted Biopsy (VAB) Drivers
    • Core Needle Biopsy (CNB) Guns
    • Automated
    • Semi-Automated
  • Biopsy Tables
    • Prone Tables
    • Upright/Add-on Tables
  • Biopsy Consumables
    • Needles & Probes
    • Site Markers & Clips
  • By Shape/Design
  • Standard Geometric Markers
    • Ring
    • Cross
    • Ribbon
    • Others
  • Advanced Anchoring Markers
    • Anchor
    • Wing, "U" Shape
    • Q" Shape
  • 3D / Expandable Markers
    • 3D Ribbon
    • 3D Sphere
    • 3D Mesh
  • Localization Systems
    • Traditional Wires
    • Wireless Seeds-RFID/Magnetic
  • Other Consumables
  • Procedure Outlook (Revenue, USD Million, 2021 - 2033)
  • Vacuum-Assisted Biopsy (VAB)
  • Core Needle Biopsy (CNB)
  • Fine Needle Aspiration Biopsy (FNAB)
  • Surgical (Open) Biopsy
  • Liquid Biopsy
  • Guidance Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Ultrasound-Guided
  • Mammography / Stereotactic-Guided
  • MRI-Guided
  • End Use Outlook (Revenue, USD Million; 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialized Breast Care Centers
  • Diagnostic Centers/Imaging Centers
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Product
    • 1.1.2. Procedure
    • 1.1.3. Guidance Technology
    • 1.1.4. End Use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
    • 1.5.1. Data for primary interviews in North America
    • 1.5.2. Data for primary interviews in Europe
    • 1.5.3. Data for primary interviews in Asia Pacific
    • 1.5.4. Data for primary interviews in Latin America
    • 1.5.5. Data for Primary interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Breast Biopsy Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Increasing burden of breast cancer
      • 3.2.1.2. Expansion of breast cancer screening programs
      • 3.2.1.3. Technological advancements in imaging-guided biopsy
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. High cost of advanced biopsy technologies
      • 3.2.2.2. Limited access to diagnostic facilities in low-resource settings
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Expansion of screening programs in emerging economies
      • 3.2.3.2. Growth of minimally invasive and rapid diagnostic technologies
      • 3.2.3.3. Integration with next-generation imaging and AI
      • 3.2.3.4. Expansion of outpatient and ambulatory care
      • 3.2.3.5. Rising demand for personalized and precision diagnostics
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Patient anxiety and procedure hesitation
      • 3.2.4.2. Limited skilled workforce
  • 3.3. Breast Biopsy Devices Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Breast Biopsy Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Breast Biopsy Devices Market: Product Movement Analysis, 2025 & 2033 (USD Million)
  • 4.3. Global Breast Biopsy Devices Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
    • 4.3.1. Biopsy Guidance Systems
      • 4.3.1.1. Biopsy guidance systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Biopsy Drivers & Handpieces
      • 4.3.2.1. Biopsy drivers & handpieces market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.2. Vacuum-assisted biopsy (VAB) drivers
        • 4.3.2.2.1. Vacuum-assisted biopsy (VAB) drivers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.3. Core needle biopsy (CNB) guns
        • 4.3.2.3.1. Core needle biopsy (CNB) guns market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.3.2. Automated
          • 4.3.2.3.2.1. Automated market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.3.3. Semi-automated
          • 4.3.2.3.3.1. Semi-automated market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Biopsy tables
      • 4.3.3.1. Biopsy tables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.2. Prone tables
        • 4.3.3.2.1. Prone tables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.3. Upright/add-on tables
        • 4.3.3.3.1. Upright/add-on tables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.4. Biopsy consumables
      • 4.3.4.1. Biopsy consumables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.4.2. Needles & probes
        • 4.3.4.2.1. Needles & probes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.4.3. Site markers & clips
        • 4.3.4.3.1. Site markers & clips market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.2. By shape/design
          • 4.3.4.3.2.1. By shape/design market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.3. Standard geometric markers
          • 4.3.4.3.3.1. Standard geometric markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.3.2. Ring
            • 4.3.4.3.3.2.1. Ring market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.3.3. Cross
            • 4.3.4.3.3.3.1. Cross market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.3.4. Ribbon
            • 4.3.4.3.3.4.1. Ribbon market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.3.5. Others
            • 4.3.4.3.3.5.1. Others markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.4. Advanced anchoring markers
          • 4.3.4.3.4.1. Advanced anchoring markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.4.2. Anchor
            • 4.3.4.3.4.2.1. Anchor markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.4.3. Wing, "U" shape
            • 4.3.4.3.4.3.1. Wing, "U" shape market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.4.4. "Q" shape
            • 4.3.4.3.4.4.1. "Q" shape markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.5. 3D / expandable markers
          • 4.3.4.3.5.1. 3D / expandable markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.5.2. 3D ribbon
            • 4.3.4.3.5.2.1. 3D ribbon market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.5.3. 3D sphere
            • 4.3.4.3.5.3.1. 3D Sphere market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.5.4. 3D Mesh
            • 4.3.4.3.5.4.1. 3D Mesh market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.4.4. Localization systems
        • 4.3.4.4.1. Localization systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.4.2. Traditional wires
          • 4.3.4.4.2.1. Traditional wires market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.4.3. Wireless Seeds-RFID/magnetic
          • 4.3.4.4.3.1. Wireless seeds-RFID/magnetic market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.5. Other Consumables
      • 4.3.5.1. Other Consumables market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Breast Biopsy Devices Market: Procedure Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Breast Biopsy Devices Market: Procedure Movement Analysis, 2025 & 2033 (USD Million)
  • 5.3. Global Breast Biopsy Devices Market Size & Trend Analysis, by Procedure, 2021 to 2033 (USD Million)
    • 5.3.1. Vacuum-Assisted Biopsy (VAB)
      • 5.3.1.1. Vacuum-assisted biopsy (VAB) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. Core Needle Biopsy (CNB)
      • 5.3.2.1. Core needle biopsy (CNB) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.3. Fine Needle Aspiration Biopsy (FNAB)
      • 5.3.3.1. Fine needle aspiration biopsy (FNAB) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.4. Surgical (Open) Biopsy
      • 5.3.4.1. Surgical (open) biopsy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.5. Liquid Biopsy
      • 5.3.5.1. Liquid biopsy market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Breast Biopsy Devices Market: Guidance Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Breast Biopsy Devices Market: Guidance Technology Movement Analysis, 2025 & 2033 (USD Million)
  • 6.3. Global Breast Biopsy Devices Market Size & Trend Analysis, by Guidance Technology, 2021 to 2033 (USD Million)
    • 6.3.1. Ultrasound-Guided
      • 6.3.1.1. Ultrasound-guided market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. Mammography / Stereotactic-Guided
      • 6.3.2.1. Mammography / stereotactic-guided market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. MRI-Guided
      • 6.3.3.1. MRI-guided market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Breast Biopsy Devices Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Breast Biopsy Devices Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
  • 7.3. Global Breast Biopsy Devices Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
    • 7.3.1. Hospitals
      • 7.3.1.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Ambulatory Surgical Centers (ASCs)
      • 7.3.2.1. Ambulatory surgical centers (ASCs) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Specialized Breast Care Centers
      • 7.3.3.1. Specialized breast care centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Diagnostic Centers/Imaging Centers
      • 7.3.4.1. Diagnostic centers/imaging centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Breast Biopsy Devices Market: Regional Estimates & Trend Analysis by Product, Procedure, Guidance Technology, and End Use

  • 8.1. Regional Dashboard
  • 8.2. Market Size and Trend Analysis, 2021 to 2033
  • 8.3. North America
    • 8.3.1. North America breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Competitive scenario
      • 8.3.2.3. Regulatory framework
      • 8.3.2.4. Reimbursement scenario
      • 8.3.2.5. U.S. breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Competitive scenario
      • 8.3.3.3. Regulatory framework
      • 8.3.3.4. Reimbursement scenario
      • 8.3.3.5. Canada breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key country dynamics
      • 8.3.4.2. Competitive scenario
      • 8.3.4.3. Regulatory framework
      • 8.3.4.4. Reimbursement scenario
      • 8.3.4.5. Mexico breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory framework
      • 8.4.2.4. Reimbursement scenario
      • 8.4.2.5. UK breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory framework
      • 8.4.3.4. Reimbursement scenario
      • 8.4.3.5. Germany breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Competitive scenario
      • 8.4.4.3. Regulatory framework
      • 8.4.4.4. Reimbursement scenario
      • 8.4.4.5. France breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Competitive scenario
      • 8.4.5.3. Regulatory framework
      • 8.4.5.4. Reimbursement scenario
      • 8.4.5.5. Italy breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Competitive scenario
      • 8.4.6.3. Regulatory framework
      • 8.4.6.4. Reimbursement scenario
      • 8.4.6.5. Spain breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Competitive scenario
      • 8.4.7.3. Regulatory framework
      • 8.4.7.4. Reimbursement scenario
      • 8.4.7.5. Sweden breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Competitive scenario
      • 8.4.8.3. Regulatory framework
      • 8.4.8.4. Reimbursement scenario
      • 8.4.8.5. Denmark breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key country dynamics
      • 8.4.9.2. Competitive scenario
      • 8.4.9.3. Regulatory framework
      • 8.4.9.4. Reimbursement scenario
      • 8.4.9.5. Norway breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory framework
      • 8.5.2.4. Reimbursement scenario
      • 8.5.2.5. China breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Japan
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory framework
      • 8.5.3.4. Reimbursement scenario
      • 8.5.3.5. Japan breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory framework
      • 8.5.4.4. Reimbursement scenario
      • 8.5.4.5. India breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory framework
      • 8.5.5.4. Reimbursement scenario
      • 8.5.5.5. South Korea breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Regulatory framework
      • 8.5.6.4. Reimbursement scenario
      • 8.5.6.5. Australia breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Competitive scenario
      • 8.5.7.3. Regulatory framework
      • 8.5.7.4. Reimbursement scenario
      • 8.5.7.5. Thailand breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. Reimbursement scenario
      • 8.6.2.5. Brazil breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive scenario
      • 8.6.3.3. Regulatory framework
      • 8.6.3.4. Reimbursement scenario
      • 8.6.3.5. Argentina breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7. Middle East and Africa
    • 8.7.1. Middle East and Africa breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Reimbursement scenario
      • 8.7.2.5. South Africa breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Competitive scenario
      • 8.7.3.3. Regulatory framework
      • 8.7.3.4. Reimbursement scenario
      • 8.7.3.5. Saudi Arabia breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Competitive scenario
      • 8.7.4.3. Regulatory framework
      • 8.7.4.4. Reimbursement scenario
      • 8.7.4.5. UAE breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Competitive scenario
      • 8.7.5.3. Regulatory framework
      • 8.7.5.4. Reimbursement scenario
      • 8.7.5.5. Kuwait breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Market Share Analysis, 2025
  • 9.4. Company Heat Map Analysis
  • 9.5. Strategy Mapping
    • 9.5.1. Expansion
    • 9.5.2. Mergers & Acquisition
    • 9.5.3. Partnerships & Collaborations
    • 9.5.4. New Product Launches
    • 9.5.5. Research And Development
    • 9.5.6. Company Profiles
    • 9.5.7. Hologic, Inc.
      • 9.5.7.1. Company overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Mammotome (Danaher)
      • 9.5.8.1. Company overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. BD
      • 9.5.9.1. Company overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. Argon Medical
      • 9.5.10.1. Company overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. Merit Medical Systems
      • 9.5.11.1. Company overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product Benchmarking
      • 9.5.11.4. Strategic initiatives
    • 9.5.12. GE HealthCare
      • 9.5.12.1. Company overview
      • 9.5.12.2. Financial performance
      • 9.5.12.3. Product Benchmarking
      • 9.5.12.4. Strategic initiatives
    • 9.5.13. Cook Medical
      • 9.5.13.1. Company overview
      • 9.5.13.2. Financial performance
      • 9.5.13.3. Product Benchmarking
      • 9.5.13.4. Strategic initiatives
    • 9.5.14. MOLLI Surgical (Stryker)
      • 9.5.14.1. Company overview
      • 9.5.14.2. Financial performance
      • 9.5.14.3. Product Benchmarking
      • 9.5.14.4. Strategic initiatives
    • 9.5.15. Planmed Oy
      • 9.5.15.1. Company overview
      • 9.5.15.2. Financial performance
      • 9.5.15.3. Product Benchmarking
      • 9.5.15.4. Strategic initiatives
    • 9.5.16. Metaltronica Spa
      • 9.5.16.1. Company overview
      • 9.5.16.2. Financial performance
      • 9.5.16.3. Product Benchmarking
      • 9.5.16.4. Strategic initiatives
    • 9.5.17. Trivitron Healthcare
      • 9.5.17.1. Company overview
      • 9.5.17.2. Financial performance
      • 9.5.17.3. Product Benchmarking
      • 9.5.17.4. Strategic initiatives
    • 9.5.18. Siemens Healthineers
      • 9.5.18.1. Company overview
      • 9.5.18.2. Financial performance
      • 9.5.18.3. Product Benchmarking
      • 9.5.18.4. Strategic initiatives
    • 9.5.19. Fujifilm Healthcare
      • 9.5.19.1. Company overview
      • 9.5.19.2. Financial performance
      • 9.5.19.3. Product Benchmarking
      • 9.5.19.4. Strategic initiatives
    • 9.5.20. INRAD
      • 9.5.20.1. Company overview
      • 9.5.20.2. Financial performance
      • 9.5.20.3. Product Benchmarking
      • 9.5.20.4. Strategic initiatives
    • 9.5.21. SteryLab
      • 9.5.21.1. Company overview
      • 9.5.21.2. Financial performance
      • 9.5.21.3. Product Benchmarking
      • 9.5.21.4. Strategic initiatives
    • 9.5.22. Resitu Medical
      • 9.5.22.1. Company overview
      • 9.5.22.2. Financial performance
      • 9.5.22.3. Product Benchmarking
      • 9.5.22.4. Strategic initiatives
    • 9.5.23. TransMed7, LLC.
      • 9.5.23.1. Company overview
      • 9.5.23.2. Financial performance
      • 9.5.23.3. Product Benchmarking
      • 9.5.23.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America breast biopsy devices market, by region 2021 - 2033 (USD Million)
  • Table 3 North America breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 4 North America breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 5 North America breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 6 North America breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 7 U.S. breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 8 U.S. breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 9 U.S. breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 10 U.S. breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 11 Canada breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 12 Canada breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 13 Canada breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 14 Canada breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 15 Mexico breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 16 Mexico breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 17 Mexico breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 18 Mexico breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 19 Europe breast biopsy devices market, by region 2021 - 2033 (USD Million)
  • Table 20 Europe breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 21 Europe breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 22 Europe breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 23 Europe breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 24 Germany breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 25 Germany breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 26 Germany breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 27 Germany breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 28 UK breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 29 UK breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 30 UK breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 31 UK breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 32 France breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 33 France breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 34 France breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 35 France breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 36 Italy breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 37 Italy breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 38 Italy breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 39 Italy breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 40 Spain breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 41 Spain breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 42 Spain breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 43 Spain breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 44 Denmark breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 45 Denmark breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 46 Denmark breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 47 Denmark breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 48 Sweden breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 49 Sweden breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 50 Sweden breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 51 Sweden breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 52 Norway breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 53 Norway breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 54 Norway breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 55 Norway breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 56 Asia Pacific breast biopsy devices market, by region 2021 - 2033 (USD Million)
  • Table 57 Asia Pacific breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 60 Asia Pacific breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 61 China breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 62 China breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 63 China breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 64 China breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 65 Japan breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 66 Japan breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 67 Japan breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 68 Japan breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 69 India breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 70 India breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 71 India breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 72 India breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 73 South Korea breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 74 South Korea breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 75 South Korea breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 76 South Korea breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 77 Australia breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 78 Australia breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 79 Australia breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 80 Australia breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 81 Thailand breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 82 Thailand breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 83 Thailand breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 84 Thailand breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 85 Latin America breast biopsy devices market, by region 2021 - 2033 (USD Million)
  • Table 86 Latin America breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 87 Latin America breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 88 Latin America breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 89 Latin America breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 90 Brazil breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 91 Brazil breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 92 Brazil breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 93 Brazil breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 94 Argentina breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 95 Argentina breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 96 Argentina breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 97 Argentina breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 98 MEA breast biopsy devices market, by region 2021 - 2033 (USD Million)
  • Table 99 MEA breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 100 MEA breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 101 MEA breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 102 MEA breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 103 South Africa breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 104 South Africa breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 105 South Africa breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 106 South Africa breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 107 Saudi Arabia breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 108 Saudi Arabia breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 109 Saudi Arabia breast biopsy devices market, by guidance technology (USD Million)
  • Table 110 Saudi Arabia breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 111 UAE breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 112 UAE breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 113 UAE breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 114 UAE breast biopsy devices market, by end use 2021 - 2033 (USD Million)
  • Table 115 Kuwait breast biopsy devices market, by product 2021 - 2033 (USD Million)
  • Table 116 Kuwait breast biopsy devices market, by procedure 2021 - 2033 (USD Million)
  • Table 117 Kuwait breast biopsy devices market, by guidance technology 2021 - 2033 (USD Million)
  • Table 118 Kuwait breast biopsy devices market, by end use 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Breast biopsy devices market segmentation.
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Data analysis models
  • Fig. 5 Market formulation and validation
  • Fig. 6 Data validating & publishing.
  • Fig. 7 Market snapshot
  • Fig. 8 Segment snapshot.
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Breast biopsy devices - market size and growth prospects (USD Million)
  • Fig. 11 Breast biopsy devices market: Industry Value Chain Analysis
  • Fig. 12 Breast biopsy devices market: Market Dynamics
  • Fig. 13 Breast biopsy devices market: PORTER's Analysis
  • Fig. 14 Breast biopsy devices market: PESTEL Analysis
  • Fig. 15 Breast biopsy devices market share by product, 2025 & 2033 (USD Million)
  • Fig. 16 Breast biopsy devices market, by product: market share, 2025 & 2033.
  • Fig. 17 Biopsy guidance systems market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 18 Biopsy drivers & handpieces market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 19 Vacuum-assisted biopsy (VAB) drivers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 20 Core needle biopsy (CNB) guns market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 21 Automated market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 22 Semi-automated market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 23 Biopsy tables market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 24 Prone tables market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 25 Upright/add-on tables market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 26 Biopsy consumables market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 27 Needles & probes market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 28 Site markers & clips market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 29 By shape/design market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 30 Standard geometric markers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 31 Ring market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 32 Cross market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 33 Others market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 34 Advanced anchoring markers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 35 Anchor market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 36 Wing, "U" shape market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 37 "Q" shape market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 38 3D / expandable markers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 39 3D ribbon market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 40 3D sphere market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 41 3D mesh market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 42 Localization systems market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 43 Traditional wires market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 44 Wireless seeds-RFID/magnetic market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 45 Other consumables market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 46 Breast biopsy devices market share by procedure, 2025 & 2033 (USD Million)
  • Fig. 47 Breast biopsy devices market, by procedure: market share, 2025 & 2033.
  • Fig. 48 Vacuum-assisted biopsy (VAB) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 49 Core needle biopsy (CNB) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 50 Fine needle aspiration biopsy (FNAB) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 51 Surgical (open) biopsy market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 52 Liquid biopsy market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 53 Breast biopsy devices market share by guidance technology, 2025 & 2033 (USD Million)
  • Fig. 54 Breast biopsy devices market, by guidance technology: market share, 2025 & 2033.
  • Fig. 55 Ultrasound-guided market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 56 Mammography / stereotactic-guided market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 57 MRI-guided market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 58 Breast biopsy devices market share by end use, 2025 & 2033 (USD Million)
  • Fig. 59 Breast biopsy devices market, by end use: market share, 2025 & 2033.
  • Fig. 60 Hospitals market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 61 Ambulatory surgical centers (ASCs) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 62 Specialized breast care centers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 63 Diagnostic centers/imaging centers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 64 Regional marketplace: key takeaways
  • Fig. 65 North America breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 U.S. breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Canada breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Mexico breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Europe breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 UK breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Germany breast biopsy devices market estimates and forecasts 2021 - 2033 (USD Million)
  • Fig. 72 France breast biopsy devices market estimates and forecasts 2021 - 2033 (USD Million)
  • Fig. 73 Italy breast biopsy devices market estimates and forecasts 2021 - 2033 (USD Million)
  • Fig. 74 Spain breast biopsy devices market estimates and forecasts 2021 - 2033 (USD Million)
  • Fig. 75 Sweden breast biopsy devices market estimates and forecasts 2021 - 2033 (USD Million)
  • Fig. 76 Denmark breast biopsy devices market estimates and forecasts 2021 - 2033 (USD Million)
  • Fig. 77 Norway breast biopsy devices market estimates and forecasts 2021 - 2033 (USD Million)
  • Fig. 78 Asia Pacific breast biopsy devices market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 79 China breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Japan breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 India breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 South Korea breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Australia breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Thailand breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Latin America breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Brazil breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Argentina breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 MEA breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 South Africa breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Saudi Arabia breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 UAE breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Kuwait breast biopsy devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 93 Key company categorization
  • Fig. 94 Company market positioning
  • Fig. 95 Key company market share analysis, 2025
  • Fig. 96 Strategic framework